細胞解離市場- 世界の産業規模、シェア、動向、競合、機会、予測、タイプ別、製品タイプ別、組織別、エンドユーザー別、地域別、競合別、2020-2030年

細胞解離の世界市場は、2024年に7億3,025万米ドルと評価され、2030年には15億4,784万米ドルに達すると予測され、予測期間中のCAGRは13.34%で成長します。

この成長は主に、バイオ医薬品分野における研究努力の拡大、個別化医療に対する需要の増加、細胞ベース研究に対する公的・政府投資の増加によってもたらされます。細胞解離は、ワクチン開発や細胞拡大プロセスなど、さまざまな応用において極めて重要なステップです。組織解離技術の進歩、幹細胞への応用研究の増加、酵素を使用しない解離方法への嗜好性が、今後数年間の市場拡大をさらに後押しすると予想されます。

市場促進要因

細胞ベースの治療と再生医療に対する需要の高まり

主な市場課題

解離後の細胞の生存性と機能的完全性

主要市場動向

自動化とハイスループット細胞解離技術

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の細胞解離市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（組織解離と細胞剥離）
  • 製品タイプ別（酵素分解製品、非酵素分解製品、機器およびアクセサリ）
  • 組織別（上皮組織、結合組織、その他）
  • エンドユーザー別（バイオテクノロジー企業、製薬会社、学術調査機関など）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 アジア太平洋地域の細胞解離市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国。
  • インド。
  • 韓国
  • 日本
  • オーストラリア

第7章 欧州の細胞解離市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 北米の細胞解離市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米の細胞解離市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの細胞解離市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品開発

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威/サービス

第14章 世界の細胞解離市場：SWOT分析

第15章 競合情勢

• Becton, Dickinson and Company
• Miltenyi Biotec
• Thermo Fisher Scientific Inc.
• GE Healthcare
• Sartorius AG
• Lonza Group Ltd.
• Danaher Corporation
• Merck KGaA
• STEMCELL Technologies
• QIAGEN N.V.

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Cell Dissociation Market was valued at USD 730.25 million in 2024 and is projected to reach USD 1,547.84 million by 2030, growing at a CAGR of 13.34% during the forecast period. This growth is primarily driven by expanding research efforts in the biopharmaceutical sector, increasing demand for personalized medicine, and rising public and government investments in cell-based research. Cell dissociation is a crucial step in various applications, including vaccine development and cell expansion processes. Advancements in tissue dissociation technologies, increased research in stem cell applications, and the preference for enzyme-free dissociation methods over enzymatic alternatives are expected to further support market expansion in the coming years.

Key Market Drivers

Rising Demand for Cell-Based Therapies and Regenerative Medicine

A major factor fueling the global cell dissociation market is the escalating demand for cell-based therapies and regenerative medicine. Cell dissociation is fundamental in isolating single cells from tissues, an essential step for downstream processes such as immunotherapy, stem cell research, and tissue engineering. Government-backed initiatives, like the U.S. Department of Health and Human Services' "Regenerative Medicine Innovation Project," which allocated over $10 million under the 21st Century Cures Act, are accelerating the adoption of these technologies. The increasing global prevalence of chronic conditions such as Parkinson's disease, cardiovascular disorders, and diabetes has also intensified the need for innovative, cell-based interventions. According to the WHO, chronic illnesses account for more than 70% of global deaths, prompting significant public and private investments in cellular therapies and, by extension, cell dissociation technologies.

Key Market Challenges

Cell Viability and Functional Integrity Post-Dissociation

Maintaining cell viability and functional integrity following dissociation remains a significant challenge in the global market. The enzymatic and mechanical processes used in dissociation can compromise cell membranes, alter surface markers, and disrupt intracellular functions, which are critical for applications like immunophenotyping, single-cell sequencing, and therapeutic use. This issue is particularly concerning in sensitive applications such as stem cell and T-cell therapies. Research funded by institutions like the NIH has shown that prolonged exposure to dissociation enzymes like trypsin can alter phenotypes and reduce the effectiveness of cell-based treatments. Additionally, the lack of standardized protocols for diverse tissue types adds variability to outcomes, impeding reproducibility and regulatory approval in translational research.

Key Market Trends

Automation and High-Throughput Cell Dissociation Technologies

A key trend shaping the cell dissociation market is the increasing adoption of automated and high-throughput technologies in laboratory workflows. Manual dissociation methods are time-intensive and susceptible to variability, particularly in high-volume or GMP-compliant settings. Automated systems streamline the dissociation process, reduce manual errors, and enhance yield and viability, making them increasingly attractive to both research institutions and commercial laboratories. These systems are essential for applications such as flow cytometry, CRISPR gene editing, and single-cell RNA sequencing. Government initiatives supporting the integration of artificial intelligence and smart technologies in biomedical research-such as the NIH's "Bridge2AI" program-are further driving the adoption of automation, ensuring more consistent and reproducible results across cell biology studies.

Key Market Players

• Becton, Dickinson and Company
• Miltenyi Biotec
• Thermo Fisher Scientific Inc.
• GE Healthcare
• Sartorius AG
• Lonza Group Ltd.
• Danaher Corporation
• Merck KGaA
• STEMCELL Technologies
• QIAGEN N.V.

Report Scope:

In this report, the Global Cell Dissociation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Dissociation Market, By Type:

• Tissue Dissociation
• Cell Detachment

Cell Dissociation Market, By Product Type:

• Enzymatic Dissociation Products
• Non-Enzymatic Dissociation Products
• Instruments & Accessories

Cell Dissociation Market, By Tissue:

• Epithelial Tissue
• Connective Tissue
• Others

Cell Dissociation Market, By End User:

• Biotechnology Companies
• Pharmaceutical Companies
• Academic and Research Institutes
• Others

Cell Dissociation Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Cell Dissociation Market.

Available Customizations:

Global Cell Dissociation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered.
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Dissociation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Tissue Dissociation & Cell Detachment)
  • 5.2.2. By Product Type (Enzymatic Dissociation Products, Non-Enzymatic Dissociation Products, and Instruments & Accessories)
  • 5.2.3. By Tissue (Epithelial Tissue, Connective Tissue, and Others)
  • 5.2.4. By End user (Biotechnology Companies, Pharmaceutical Companies, Academic and Research Institutes and others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. Asia-Pacific Cell Dissociation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Product Type
  • 6.2.3. By Tissue
  • 6.2.4. By End user
  • 6.2.5. By Country
• 6.3. Asia-Pacific: Country Analysis
  • 6.3.1. China Cell Dissociation Market Outlook.
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Product Type
      • 6.3.1.2.3. By Tissue
      • 6.3.1.2.4. By End user
  • 6.3.2. India Cell Dissociation Market Outlook.
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Product Type
      • 6.3.2.2.3. By Tissue
      • 6.3.2.2.4. By End user
  • 6.3.3. South Korea Cell Dissociation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Product Type
      • 6.3.3.2.3. By Tissue
      • 6.3.3.2.4. By End user
  • 6.3.4. Japan Cell Dissociation Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By Product Type
      • 6.3.4.2.3. By Tissue
      • 6.3.4.2.4. By End user
  • 6.3.5. Australia Cell Dissociation Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By Product Type
      • 6.3.5.2.3. By Tissue
      • 6.3.5.2.4. By End user

7. Europe Cell Dissociation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Product Type
  • 7.2.3. By Tissue
  • 7.2.4. By End user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Cell Dissociation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Product Type
      • 7.3.1.2.3. By Tissue
      • 7.3.1.2.4. By End user
  • 7.3.2. Germany Cell Dissociation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Product Type
      • 7.3.2.2.3. By Tissue
      • 7.3.2.2.4. By End user
  • 7.3.3. United Kingdom Cell Dissociation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Product Type
      • 7.3.3.2.3. By Tissue
      • 7.3.3.2.4. By End user
  • 7.3.4. Italy Cell Dissociation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Product Type
      • 7.3.4.2.3. By Tissue
      • 7.3.4.2.4. By End user
  • 7.3.5. Spain Cell Dissociation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Product Type
      • 7.3.5.2.3. By Tissue
      • 7.3.5.2.4. By End user

8. North America Cell Dissociation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Product Type
  • 8.2.3. By Tissue
  • 8.2.4. By End user
  • 8.2.5. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Cell Dissociation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Product Type
      • 8.3.1.2.3. By Tissue
      • 8.3.1.2.4. By End user
  • 8.3.2. Mexico Cell Dissociation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Product Type
      • 8.3.2.2.3. By Tissue
      • 8.3.2.2.4. By End user
  • 8.3.3. Canada Cell Dissociation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Product Type
      • 8.3.3.2.3. By Tissue
      • 8.3.3.2.4. By End user

9. South America Cell Dissociation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Product Type
  • 9.2.3. By Tissue
  • 9.2.4. By End user
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cell Dissociation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Product Type
      • 9.3.1.2.3. By Tissue
      • 9.3.1.2.4. By End user
  • 9.3.2. Argentina Cell Dissociation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Product Type
      • 9.3.2.2.3. By Tissue
      • 9.3.2.2.4. By End user
  • 9.3.3. Colombia Cell Dissociation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Product Type
      • 9.3.3.2.3. By Tissue
      • 9.3.3.2.4. By End user

10. Middle East and Africa Cell Dissociation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Product Type
  • 10.2.3. By Tissue
  • 10.2.4. By End user
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cell Dissociation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Product Type
      • 10.3.1.2.3. By Tissue
      • 10.3.1.2.4. By End user
  • 10.3.2. Saudi Arabia Cell Dissociation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Product Type
      • 10.3.2.2.3. By Tissue
      • 10.3.2.2.4. By End user
  • 10.3.3. UAE Cell Dissociation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Product Type
      • 10.3.3.2.3. By Tissue
      • 10.3.3.2.4. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products/Services

14. Global Cell Dissociation Market: SWOT Analysis

15. Competitive Landscape

• 15.1. Becton, Dickinson and Company
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Miltenyi Biotec
• 15.3. Thermo Fisher Scientific Inc.
• 15.4. GE Healthcare
• 15.5. Sartorius AG
• 15.6. Lonza Group Ltd.
• 15.7. Danaher Corporation
• 15.8. Merck KGaA
• 15.9. STEMCELL Technologies
• 15.10. QIAGEN N.V.

16. Strategic Recommendations

17. About Us & Disclaimer